#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Oxidative DNA damage and oxidized low density lipoprotein in Type II diabetes mellitus among patients with Helicobacter pylori infection


Background:
Helicobacter pylori (H. pylori) infection is reported to be associated with various extragastrointestinal conditions such as insulin resistance, diabetes mellitus and metabolic syndrome. H. pylori infection and type 2 diabetes mellitus (T2DM) are associated with oxidative stress, this cross-relation between H. pyloriinduced infection in T2DM and oxidative damage is still debated. Thus, the question arises whether an increase in the serum level of 8-OHdG and Ox-LDL will occurs in patients with T2DM infected H. pylori; this will be through determination and compare frequency of H. pylori infection in T2DM and non-diabetic patients.

Methods:
100 patients presented with history of epigastric discomfort for more than 1 month; 50 patients with T2DM and 50 non-diabetics. Anti-H. pylori IgG using ELISA, fasting and postprandial glucose level, glycated hemoglobin (HbA1c) and body mass index (BMI) was calculated. Serum 8-OHdG and Ox-LDL was measured using ELISA for the 100 patients and 50 control subject.

Results:
Rates of H. pylori infection of T2DM and non-diabetic were 66 and 58 %, respectively, (p = 0.001). H. pylori IgG antibody was not correlated with HbA1c either in T2DM (p = 0.06) or non-diabetic (p = 0.25). Serum 8-OHdG level in T2DM with positive H. pylori infection showed a significant difference compared to non-diabetics with positive H. pylori infection (p = 0.001) and higher than that in T2DM with negative H. pylori. A correlation between 8-OHdG concentration and HbA1c in T2DM patients infected with H. pylori was observed (r = 0.39, p = 0.02). Serum Ox-LDL level in T2DM with positive H. pylori infection showed a significant difference compared to diabetics with both negative H. pylori infection and in non-diabetics with positive H. pylori infection (p = 0.001).

Conclusions:
Increased levels of oxidative DNA damage (8-OHdG) and Ox-LDL suggest the mechanistic link between H. pylori infection combined with diabetes and increased generation of ROS and could play as an important image for high risk to atherosclerosis.

Keywords:
Helicobacter pylori, Type 2 diabetes mellitus, 8-Hydroxydeoxyguanosine, Oxidized low density lipoprotein


Autoři: Wesam Ahmed Nasif 1,2*;  Mohammed Hasan Mukhtar 1;  Mohammed Mahmoud Nour Eldein 1,3;  And Sami Sadagah Ashgar 4
Působiště autorů: Biochemistry Department, Faculty of Medicine, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia. 1;  Molecular Biology Department, Genetic Engineering and Biotechnology Research Institute, Sadat City University, Sadat City, Egypt. 2;  Oncology Diagnostic Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt. 3;  Microbiology Department, Faculty of Medicine, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia. 4
Vyšlo v časopise: Diabetol Metab Syndr (2016), 8:34
Kategorie: Research
prolekare.web.journal.doi_sk: https://doi.org/10.1186/s13098-016-0149-1

© 2016 Nasif et al.

Open Access
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
The electronic version of this article is the complete one and can be found online at: https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-016-0149-1

Souhrn

Background:
Helicobacter pylori (H. pylori) infection is reported to be associated with various extragastrointestinal conditions such as insulin resistance, diabetes mellitus and metabolic syndrome. H. pylori infection and type 2 diabetes mellitus (T2DM) are associated with oxidative stress, this cross-relation between H. pyloriinduced infection in T2DM and oxidative damage is still debated. Thus, the question arises whether an increase in the serum level of 8-OHdG and Ox-LDL will occurs in patients with T2DM infected H. pylori; this will be through determination and compare frequency of H. pylori infection in T2DM and non-diabetic patients.

Methods:
100 patients presented with history of epigastric discomfort for more than 1 month; 50 patients with T2DM and 50 non-diabetics. Anti-H. pylori IgG using ELISA, fasting and postprandial glucose level, glycated hemoglobin (HbA1c) and body mass index (BMI) was calculated. Serum 8-OHdG and Ox-LDL was measured using ELISA for the 100 patients and 50 control subject.

Results:
Rates of H. pylori infection of T2DM and non-diabetic were 66 and 58 %, respectively, (p = 0.001). H. pylori IgG antibody was not correlated with HbA1c either in T2DM (p = 0.06) or non-diabetic (p = 0.25). Serum 8-OHdG level in T2DM with positive H. pylori infection showed a significant difference compared to non-diabetics with positive H. pylori infection (p = 0.001) and higher than that in T2DM with negative H. pylori. A correlation between 8-OHdG concentration and HbA1c in T2DM patients infected with H. pylori was observed (r = 0.39, p = 0.02). Serum Ox-LDL level in T2DM with positive H. pylori infection showed a significant difference compared to diabetics with both negative H. pylori infection and in non-diabetics with positive H. pylori infection (p = 0.001).

Conclusions:
Increased levels of oxidative DNA damage (8-OHdG) and Ox-LDL suggest the mechanistic link between H. pylori infection combined with diabetes and increased generation of ROS and could play as an important image for high risk to atherosclerosis.

Keywords:
Helicobacter pylori, Type 2 diabetes mellitus, 8-Hydroxydeoxyguanosine, Oxidized low density lipoprotein


Zdroje

1. Yang Bi-Ling, Yeh Chun, Kwong Wei-Gang, Lee Shou-Dong. A novel one-step Helicobacter pylori saliva antigen test. J Chin Med Assoc. 2015;78:96–100.

2. Wang F, Fu Y, Lv Z. Association of Helicobacter pylori infection with diabetic complications: a meta-analysis. Endocr Res. 2014;39:7–12.

3. Dogan Zeynal, Sarikaya Murat, Ergul Bilal, Filik Levent. The effect of Helicobacter pylori eradication on insulin resistance and HbA1c level in people with normal glucose levels: a prospective study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159(2):242–5.

4. Wong F, Rayner-Hartley E, Byrne MF. Extraintestinal manifestations of Helicobacter pylori: a concise review. World J Gastroenterol. 2014;20:11950–61.

5. Masoud S, Yousef R, Zahra S, Fariba K, Mohammad R. The effect of Helicobacter pylori infection on oxidative stress status in erosive reflux disease. Med J DY Patil Univ. 2013;6:55–9.

6. Tsang KW, Lam SK. Extragastroduodenal conditions associated with Helicobacter pylori infection. Hong Kong Med J. 1999;5:169–74.

7. Malamug LR, Karnchanasorn R, Samoa R, Chiu KC. The role of Helicobacter pylori seropositivity in insulin sensitivity, beta cell function and abnormal glucose tolerance. Scientifica. 2014;2014:870165 (10 pages).

8. Guo X, Zhao BH, Zhang MX. Risk factors of Helicobacter pylori infection among adults in Northern China. Hepatogastroenterology. 2011;58:306–10.

9. Simon L, Tornóczky J, Tóth M, Jámbor M, Sudár Z. The significance of Campylobacter pylori infection in gastroenterologic and diabetic practice. Orv Hetil. 1989;130:1325–9.

10. Devrajani BR, Shah SZ, Soomro AA, Devrajani T. Type 2 diabetes mellitus: a risk factor for Helicobacter pylori infection: A hospital based case-control study. Int J Diabetes Dev Ctries. 2010;30:22–6.

11. Bener A, Micallef R, Afifi M, Derbala M, Al-Mulla HM, Usmani MA. Association between type 2 diabetes mellitus and Helicobacter pylori infection. Turk J Gastroenterol. 2007;18:225–9.

12. Stanciu OG, Trifan A, Sfarti C, Cojocariu C, Stanciu C. Helicobacter pylori infection in patients with diabetes mellitus. Rev Med Chir Soc Med Nat Iasi. 2003;107:59–65.

13. Anastasios R, Goritsas C, Papamihail C, Trigidou R, Garzonis P, Ferti A. Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings. Eur J Intern Med. 2002;13:376.

14. He C, Yang Z, Lu NH. Helicobacter pylori infection and diabetes: is it a myth or fact? World J Gastroenterol. 2014;20:4607–17.

15. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am

Soc Nephrol. 2002;13:1894–900.

16. Moss SF, Legon S, Bishop AE, Polak JM, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet. 1992;340:930–2.

17. Aydemir S, Bayraktaroglu T, Sert M, Sokmen C, Atmaca H, Mungan G, Gun BD, Borazan A, Ustundag Y. The effect of Helicobacter pylori on insulin resistance. Dig Dis Sci. 2005;50:2090–3.

18. Jackson L, Britton J, Lewis SA, McKeever TM, Atherton J, Fullerton D, Fogarty AW. A population-based epidemiologic study of Helicobacter pylori infection and its association with systemic inflammation. Helicobacter. 2009;14:108–13.

19. Hamed SA, Amine NF, Galal GM, Helal SR, Tag El-Din LM, Shawky OA, Ahmed EA, Abdel Rahman MS. Vascular risks and complications in diabetes mellitus: the role of Helicobacter pylori infection. J Stroke Cerebrovasc Dis. 2008;17:86–94.

20. Kathryn EW, Gökhan SH. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111–9.

21. Ma Y, Zhang L, Rong S, Qu H, Zhang Y, Chang D, Pan H, Wang W. Relation between gastric cancer and protein oxidation, dna damage, and lipid peroxidation. Oxid Med Cell Longev. 2013;2013:543760 (6 pages).

22. Marin MT, Dasari PS, Tryggestad JB, Aston CE, Teague AM, Short KR. Oxidized HDL and LDL in adolescents with type 2 diabetes compared to normal weight and obese peers. J Diabetes Complications. 2015;29:679–85.

23. Aslan M, Horoz M, Nazligul Y, Bolukbas C, Bolukbas FF, Selek S, Celik H, Erel O. Insulin resistance in H pylori infection and its association with oxidative stress. World J Gastroenterol. 2006;14:6865–8.

24. Kayo S, Ohsawa M, Ehara S, Naruko T, Ikura Y, Hai E, Yoshimi N, Shirai N, Tsukamoto Y, Itabe H, Higuchi K, Arakawa T, Ueda M. Oxidized low-density lipoprotein levels circulating in plasma and deposited in the tissues: comparison between Helicobacter pylori-associated gastritis and acute myocardial infarction. Am Heart J. 2004;148:818–25.

25. Nowotny K, Jung T, Höhn A, Weber D, Grune T. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules. 2015;5:194–222.

26. Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes. 2015;6:456–80.

27. Pi J, Bai Y, Zhang Q, Wong V, Floering LM, Daniel K, Reece JM, Deeney JT, Andersen ME, Corkey BE, Collins S. Reactive oxygen species as a signal in glucose stimulated insulin secretion. Diabetes. 2007;56:1783–93.

28. Aqeela H, Hamid JQ, Shahid H, Waqas S. Assessment of oxidized low density lipoprotein, as atherosclerosis risk marker in type 1 diabetic children with short history of diabetes mellitus. Pak J Physiol. 2010;6:32–5.

29. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR-γ. Cell. 1998;93:229–40.

30. Ock CY, Kim EH, Choi DJ, Lee HJ, Hahm KB, Chung MH. 8-Hydroxydeoxyguanosine: not mere biomarker for oxidative stress, but remedy for oxidative stress-implicated gastrointestinal diseases. World J Gastroenterol. 2012;28:302–8.

31. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicoter T. Oxidative damage to DNA in diabetes mellitus. Lancet. 1996;347:444–5.

32. Poulsen HE, Nadal LL, Broedbaek K, Nielsen PE, Weimann A. Detection and interpretation of 8-oxodG and 8-oxoGua in urine, plasma and cerebrospinal fluid. Biochimica Biophysica Acta. 2014;1840:801–8.

33. Hardbower DM, Peek RM Jr, Wilson KT. At the Bench: helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer. J Leukoc Biol. 2014;96:201–12.

34. Gasbarrini A, Ojetti V, Pitocco D, De Luca A, Franceschi F, Candelli M. Sanz Torre E, Pola P, Ghirlanda G, Gasbarrini G: helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus. Eur J Gastroenterol Hepatol. 1998;10:469–72.

35. Oldenburg B, Diepersloot RJ, Hoekstra JB. High seroprevalence of Helicobacter pylori in diabetes mellitus patients. Dig Dis Sci. 1996;41:458–61.

36. Gulcelik NE, Kaya E, Demirbas B, Culha C, Koc G, Ozkaya M, Cakal E, Serter R, Aral Y. Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy. J Endocrinol Invest. 2005;28:214–7.

37. Shrestha R, Koirala K, Raj KC, Batajoo KH. Helicobacter pylori Infection among Patients with Upper Gastrointestinal Symptoms: prevalence and Relation to Endoscopy Diagnosis and Histopathology. J Family Med Prim Care. 2014;3:154–8.

38. Talebi-Taher M, Mashayekhi M, Hashemi MH, Bahrani V. Helicobacter pylori in diabetic and non-diabetic patients with dyspepsia. Acta Medica Iranica. 2012;50:315–8.

39. Xia HH, Talley NJ, Kam EP, Young LJ, Hammer J, Horowitz M. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol. 2001;96:1039–46.

40. Demir M, Gokturk HS, Ozturk NA, Kulaksizoglu M, Serin E, Yilmaz U. Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications. Dig Dis Sci. 2008;53:2646–9.

41. Ferdinando G, Michael B. Ann Marie S, Guest E: Oxidative Stress and Diabetic Complications. Circ Res. 2010;107:1058–70.

42. Johannes GK, Arnoud HM, Ernst JK. Pathogenesis of Helicobacter pylori Infection. Clin Microbiol Rev. 2006;19:449–90.

43. Koichi O. Effect of glycemic control on plasma oxidized low density lipoprotein levels in diabetics. Sci J Clin Med. 2014;3:91–7.

44. Maiolino G, Rossitto G, Caielli P, Bisogni V, Rossi GP, Calò LA. The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. Mediators Inflamm. 2013;2013:714653 (13 pages).

45. Vafaeimanesh J, Hejazi SF, Damanpak V, Vahedian M, Sattari M, Seyyedmajidi M. Association of Helicobacter pylori infection with coronary artery disease: is Helicobacter pylori a risk factor? Sci World J. 2014;2014:516354 (6 pages).

46. Toshima S, Hasegawa A, Kurabayashi M, Itabe H, Takano T, Sugano J, Shimamura K, Kimura J, Michishita I, Suzuki T, Nagai R. Circulating oxidized low density lipoprotein levels a biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol. 2000;20:2243–7.

47. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, Komatsu R, Matsuo T, Itabe H, Takano T, Tsukamoto Y, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation. 2001;103:1955–60.

48. Kugiyama K, Sugiyama S, Soejima H, Kawano H, Sakamoto T, Takazoe K, Ogawa H, Doi H, Yasue H. Increase in plasma levels of oxidized lowdensity lipoproteins in patients with coronary spastic angina. Atherosclerosis. 2001;154:463–7.

49. Carr AC, McCall MR, Frei B. Oxidation of LDL by Myeloperoxidase and reactive nitrogen species reaction pathways and antioxidant protection”. Arterioscler Thromb Vasc Biol. 2000;20:1716–23.

50. Rehman A, Nourooz-Zadeh J, Möller W, Tritschler H, Pereira P, Halliwell B. Increased oxidative damage to all DNA bases in patients with type II diabetes mellitus. FEBS Lett. 1999;448:120–2.

51. Collins AR, Raslová K, Somorovská M, Petrovská H, Ondrusová A, Vohnout B, Fábry R, Dusinská M. DNA damage in diabetes: correlation with a clinical marker. Free Radic Biol Med. 1998;25:373–7.

52. Wright E Jr, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract. 2006;60:308–14.

Štítky
Diabetológia Kardiológia Obezitológia
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#